Erenumab for Idiosyncratic Facial Pain

NCT04249427 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Facial Pain
Rhinosinusitis

Interventions

DRUG: Erenumab Prefilled Syringe
OTHER: Placebo

Sponsor

David Jang, M.D.

Collaborators

[object Object]